Human calcitonin radioimmunoassay: characterization and application

Area of Science:

• Endocrinology
• Biochemistry
• Immunology

Background:

• Calcitonin is a hormone crucial for calcium regulation.
• Accurate measurement of human calcitonin (HCT) is essential for understanding various physiological and pathological states.

Purpose of the Study:

• To develop and validate a sensitive and reproducible radioimmunoassay for human calcitonin (HCT).
• To assess the utility of the HCT assay in different clinical conditions and physiological states.

Main Methods:

• Development of a radioimmunoassay using antibodies against a HCT-bovine gamma globulin conjugate.
• Validation of assay sensitivity (limit of detection 30 pg/ml), reproducibility, and specificity for intact HCT and its fragments.
• Measurement of serum HCT levels in normal subjects, cord sera, patients with chronic renal disease, medullary thyroid cancer, pregnant women, and those with chronic hypercalcemia.

Main Results:

• The developed radioimmunoassay demonstrated high sensitivity, reproducibility, and specificity.
• Serum HCT was detected in 76% of normal subjects (mean 72 pg/ml).
• Elevated HCT levels were observed in cord sera, chronic renal disease, and medullary thyroid cancer patients, and during calcium infusion in normal subjects. No significant correlation was found between serum ionized calcium and HCT.

Conclusions:

• The developed radioimmunoassay is a valuable tool for measuring human calcitonin (HCT).
• The assay can detect alterations in HCT levels associated with specific medical conditions, contributing to the study of calcitonin homeostasis.
• Further research utilizing this assay is warranted to explore calcitonin's role in various health and disease states.